Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478497 · ClinicalTrials.gov registry record · NA
30 Day Insulin Balance Metabolic Health Optimization Protocol
A NA study of Insulin, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07478497 is a NA study of Insulin that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, above the 65-participant average among 6 other Insulin trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07478497, a NA study of Insulin, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is designed for people who are generally healthy and want to support and maintain healthy insulin levels to reach general health goals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Insulin Balance Formula - Hormetics Weight Optimization System
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2026-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07478497
The ClinicalTrials.gov registry entry for NCT07478497 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 65-participant average among 6 other Insulin trials with a reported enrollment target (54% higher). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin appearing as the primary indexed condition, and to 1 intervention - of which Insulin Balance Formula - Hormetics Weight Optimization System is the first listed.
NCT07478497 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07478497 about?
NCT07478497 is a clinical study titled "30 Day Insulin Balance Metabolic Health Optimization Protocol". Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is designed for people who are generally healthy and want to support and maintain healthy insulin level...
What is the current status of trial NCT07478497?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-21. Estimated completion is 2026-10-21.
What conditions does trial NCT07478497 study?
This clinical trial studies the following conditions: Insulin.
What interventions are being tested in trial NCT07478497?
The interventions under investigation include: Insulin Balance Formula - Hormetics Weight Optimization System (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07478497?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07478497 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
RECRUITING · NA
-
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
RECRUITING · Phase 2
-
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
COMPLETED
-
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
COMPLETED · Phase 2
-
Effect of High-Legume Diet on Colorectal Cancer Risk
COMPLETED · Early Phase 1
-
Effect of Diet on Vascular Disease in Pre-Menopausal Women
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.